Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.42 USD | +1.12% | -3.90% | +22.41% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
- Stock Market
- Equities
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Total Return chart